Barentz, a major distributor of life science ingredients, has been named the exclusive US distributor for MEGGLE GmbH & Co. – Business Unit Excipients, a leading manufacturer of pharmaceutical-grade lactose and co-processed excipients. MEGGLE, with over 70 years of experience in the pharmaceutical market and a wide range of lactose products, is headquartered in Wasserburg am Inn, Germany. Lactose is a commonly used carrier in many pharmaceutical dosage forms.
Through Barentz' regulatory support, technical sales team, exceptional customer service, and industry expertise, together with MEGGLE's extensive knowledge and experience, they will offer differentiated value-added solutions to customers. This agreement creates a strategic partnership that enables both companies to expand in the US pharmaceutical market.
Divya Tewari, President - Pharmaceuticals at Barentz, said, "We are thrilled to partner with MEGGLE, a worldwide market leader in providing high-quality, specialized lactose products. This lactose product line further enhances Barentz' existing product portfolio, and MEGGLE's local manufacturing plant helps address the current supply chain challenges in the market."
Ruth Leinenbach, Director Business Unit Excipients at MEGGLE, stated, "Barentz' industry knowledge, customer focus, and capabilities make them the perfect partner for distributing our excipient portfolio in the USA. This strategic partnership is the ideal platform to supply the US pharmaceutical market with our high-quality excipients from Germany and the USA. Our local production provides benefits, especially for American customers, in the areas of supply security, lead times, and sustainable sourcing. With Barentz at our side, we can meet these fundamental customer needs in the best way possible."
Anthony Litchfield, Global VP Pharma division, remarked, "Barentz has enjoyed a long and successful partnership with MEGGLE in several European countries, and we are delighted to extend our collaboration to the USA."
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!